| Nicholas G Vance, MD | |
|
24 Physicians Drive, Jackson, TN 38305-2070 | |
| (731) 661-9825 | |
| (731) 668-6757 |
| Full Name | Nicholas G Vance |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 13 Years |
| Location | 24 Physicians Drive, Jackson, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760774616 | NPI | - | NPPES |
| Q031011 | Medicaid | TN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Volunteer Home Care | Humboldt, TN | Home health agency |
| Medical Center Home Health | Jackson, TN | Home health agency |
| Jackson-madison County General Hospital | Jackson, TN | Hospital |
| Volunteer Community Hospital | Martin, TN | Hospital |
| Baptist Memorial Hospital - Carroll County | Huntingdon, TN | Hospital |
| Baptist Memorial Hospital Union City | Union city, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Tennessee Bone And Joint Clinic Pc | 7517940182 | 59 |
News Archive
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University developing novel nanotherapeutics for clearing obstructed blood vessels have teamed up with researchers at University of Massachusetts' New England Center for Stroke Research (NECSTR) to develop a new, highly effective drug-device combination for treating life-threatening blood clots in patients with stroke.
Medivation, Inc. (Nasdaq: MDVN) today announced treatment of the first patient in a Phase 3 clinical trial of the investigational drug MDV3100 in advanced prostate cancer. Known as AFFIRM, the trial will evaluate the novel androgen receptor antagonist MDV3100 in men with castration-resistant prostate cancer who were previously treated with docetaxel-based chemotherapy.
A recent study by researchers in California and published on the preprint server bioRxiv* in June 2020 shows that advancing age is associated with increased expression of pattern recognition receptor (PRR) genes and ACE2 receptors, possibly accounting in part for the increased severity of the disease in older adults.
Healthcare Realty Trust Incorporated today announced results for the fourth quarter ended December 31, 2012.
Catching deadly diseases like cancer early on is key to improving patient survival odds. However, diseases are much harder to diagnose in their preliminary stages because people often haven't developed symptoms yet and only trace amounts can be found in their bodies.
› Verified 3 days ago
| Entity Name | West Tennessee Bone And Joint Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831312461 PECOS PAC ID: 7517940182 Enrollment ID: O20040612000702 |
News Archive
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University developing novel nanotherapeutics for clearing obstructed blood vessels have teamed up with researchers at University of Massachusetts' New England Center for Stroke Research (NECSTR) to develop a new, highly effective drug-device combination for treating life-threatening blood clots in patients with stroke.
Medivation, Inc. (Nasdaq: MDVN) today announced treatment of the first patient in a Phase 3 clinical trial of the investigational drug MDV3100 in advanced prostate cancer. Known as AFFIRM, the trial will evaluate the novel androgen receptor antagonist MDV3100 in men with castration-resistant prostate cancer who were previously treated with docetaxel-based chemotherapy.
A recent study by researchers in California and published on the preprint server bioRxiv* in June 2020 shows that advancing age is associated with increased expression of pattern recognition receptor (PRR) genes and ACE2 receptors, possibly accounting in part for the increased severity of the disease in older adults.
Healthcare Realty Trust Incorporated today announced results for the fourth quarter ended December 31, 2012.
Catching deadly diseases like cancer early on is key to improving patient survival odds. However, diseases are much harder to diagnose in their preliminary stages because people often haven't developed symptoms yet and only trace amounts can be found in their bodies.
› Verified 3 days ago
| Entity Name | Stn Care Of Tn Ii, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518420272 PECOS PAC ID: 1759719669 Enrollment ID: O20200306001578 |
News Archive
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University developing novel nanotherapeutics for clearing obstructed blood vessels have teamed up with researchers at University of Massachusetts' New England Center for Stroke Research (NECSTR) to develop a new, highly effective drug-device combination for treating life-threatening blood clots in patients with stroke.
Medivation, Inc. (Nasdaq: MDVN) today announced treatment of the first patient in a Phase 3 clinical trial of the investigational drug MDV3100 in advanced prostate cancer. Known as AFFIRM, the trial will evaluate the novel androgen receptor antagonist MDV3100 in men with castration-resistant prostate cancer who were previously treated with docetaxel-based chemotherapy.
A recent study by researchers in California and published on the preprint server bioRxiv* in June 2020 shows that advancing age is associated with increased expression of pattern recognition receptor (PRR) genes and ACE2 receptors, possibly accounting in part for the increased severity of the disease in older adults.
Healthcare Realty Trust Incorporated today announced results for the fourth quarter ended December 31, 2012.
Catching deadly diseases like cancer early on is key to improving patient survival odds. However, diseases are much harder to diagnose in their preliminary stages because people often haven't developed symptoms yet and only trace amounts can be found in their bodies.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas G Vance, MD 24 Physicians Drive, Jackson, TN 38305-2070 Ph: (731) 661-9825 | Nicholas G Vance, MD 24 Physicians Drive, Jackson, TN 38305-2070 Ph: (731) 661-9825 |
News Archive
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University developing novel nanotherapeutics for clearing obstructed blood vessels have teamed up with researchers at University of Massachusetts' New England Center for Stroke Research (NECSTR) to develop a new, highly effective drug-device combination for treating life-threatening blood clots in patients with stroke.
Medivation, Inc. (Nasdaq: MDVN) today announced treatment of the first patient in a Phase 3 clinical trial of the investigational drug MDV3100 in advanced prostate cancer. Known as AFFIRM, the trial will evaluate the novel androgen receptor antagonist MDV3100 in men with castration-resistant prostate cancer who were previously treated with docetaxel-based chemotherapy.
A recent study by researchers in California and published on the preprint server bioRxiv* in June 2020 shows that advancing age is associated with increased expression of pattern recognition receptor (PRR) genes and ACE2 receptors, possibly accounting in part for the increased severity of the disease in older adults.
Healthcare Realty Trust Incorporated today announced results for the fourth quarter ended December 31, 2012.
Catching deadly diseases like cancer early on is key to improving patient survival odds. However, diseases are much harder to diagnose in their preliminary stages because people often haven't developed symptoms yet and only trace amounts can be found in their bodies.
› Verified 3 days ago
John Patrick Masterson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 569 Skyline Dr, Suite 100, Jackson, TN 38301 Phone: 731-427-7888 Fax: 731-265-4152 | |
Keith Douglas Nord, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 111 Stonebridge Blvd, Jackson, TN 38305 Phone: 731-427-7888 Fax: 731-265-4159 | |
L David Johnson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Physicians Dr, Jackson, TN 38305 Phone: 731-661-9825 Fax: 731-668-6757 | |
William Stansul Ragon Jr., M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Physicians Dr, Jackson, TN 38305 Phone: 731-661-9825 Fax: 731-668-6757 | |
John E Everett, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 24 Physicians Dr, Jackson, TN 38063 Phone: 731-661-9825 Fax: 731-668-6757 | |
John Douglas Haltom Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Physicians Dr, Jackson, TN 38305 Phone: 731-661-9825 Fax: 731-668-6757 | |
Jason T Hutchison, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Physicians Dr, Jackson, TN 38305 Phone: 731-661-9825 Fax: 731-668-6757 |